openPR Logo
Press release

Peptide Based Cardiovascular Therapeutics Market Inclined to Deliver Positive Growth Results until 2022 || Top Matket Players- AstraZeneca, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Pfizer, Apotex Holdings, Dr. Reddy's Laboratories Limited, Fresenius Ka

12-10-2018 11:33 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics. Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth. However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.

Request For Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=191

4 Forecast Highlights on Global Peptide Based Cardiovascular Therapeutics Market

As per the forecast of Fact.MR, the eptifibatide segment is slated to touch a value of nearly US$ 600 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The eptifibatide segment is estimated to account for nearly one-third of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.

As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 425 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.  
As per the forecast of Fact.MR, North America peptide based cardiovascular therapeutics market is expected to register a robust CAGR over the forecast period and to be valued at nearly US$ 830 Mn by 2022 end.

As perFact.MR forecasts, US peptide based cardiovascular therapeutics market is estimated to account for 88.6% revenue share of the global peptide based cardiovascular therapeutics market by 2017 end and is expected to gain market share by 2022 over 2017

North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue

The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

View Full Report with Table of Content @ https://www.factmr.com/report/191/peptide-based-cardiovascular-therapeutics-market

Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022

As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.  

Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Inc., Pfizer Inc, Apotex Holdings, Inc., Dr. Reddy's Laboratories Limited, Fresenius Kabi USA, LLC, Novetide Ltd and Amneal Pharmaceuticals LLC.

Table of Content:

Global Peptide Based Cardiovascular Therapeutics Market - Executive Summary
Global Peptide Based Cardiovascular Therapeutics Market Overview
2.1. Introduction
     2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy
     2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition
2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022
     3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
              3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
Continued……………..

Peptide Based Cardiovascular Therapeutics Market Report is available for Purchase @ https://www.factmr.com/checkout/191/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Cardiovascular Therapeutics Market Inclined to Deliver Positive Growth Results until 2022 || Top Matket Players- AstraZeneca, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Pfizer, Apotex Holdings, Dr. Reddy's Laboratories Limited, Fresenius Ka here

News-ID: 1428275 • Views:

More Releases from Fact.MR

USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo …
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%. To access the complete data tables and in-depth insights,
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future …
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035. To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: Key Developments and Future Scope
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K …
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025. To access the complete
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut …
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors. To access the complete data tables and in-depth insights, request a Discount On The Report here:

All 5 Releases


More Releases for Cardiovascular

Cardiovascular Medical Lasers: A Leading Driver Behind Rising Cardiovascular Dis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Cardiovascular Medical Lasers Industry Market Size Be by 2025? The market size for cardiovascular medical lasers has experienced substantial growth of late. From 2024 to 2025, the market is projected to expand from $0.31 billion to $0.44 billion, with a compound annual growth rate (CAGR) of
Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cardiovascular Medical Lasers Market Size By 2025? In recent times, there has been a significant expansion in the market size of cardiovascular medical lasers. Projections indicate a surge from $0.31 billion in 2024 to $0.45 billion in 2025, reflecting a compound annual growth rate (CAGR)
Rising Prevalence Of Cardiovascular Disorders Fuels Growth In The Cardiovascular …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cardiovascular Devices Market Through 2025? In recent times, there has been a significant expansion in the cardiovascular devices market size. It is expected to surge from $73.14 billion in 2024 to $79.78 billion in 2025, reflecting a compound annual growth rate (CAGR)
Impact Of Increasing Cardiovascular Disease Patients On The Cardiovascular Infor …
The Cardiovascular Information System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Cardiovascular Information System Market Size and Its Estimated Growth Rate? The cardiovascular information system market has seen strong growth in recent years. It will rise from $1.16 billion in 2024
Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solution …
The Cardiovascular Digital Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiovascular Digital Solutions Market Size During the Forecast Period? The market size for cardiovascular digital solutions has been experiencing robust growth in the past few years. The forecast suggests it
Cardiovascular Devices Market - Heart-Centric Innovations: Elevating Cardiovascu …
Newark, New Castle, USA: The "Cardiovascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiovascular Devices Market: https://www.growthplusreports.com/report/cardiovascular-devices-market/7791 This latest report researches the industry structure, sales, revenue,